Literature DB >> 19381865

Early-onset hyperargininaemia: a severe disorder?

M Schiff1, J-F Benoist, M L Cardoso, M Elmaleh-Bergès, P Forey, J Santiago, H Ogier de Baulny.   

Abstract

UNLABELLED: Hyperargininaemia is a rare inborn error of metabolism due to a defect in the final step of the urea cycle. Infantile onset is the most common presentation with recurrent vomiting and psychomotor delay associated with spastic paraparesis; chronic hyperammonaemia is often overlooked. Neonatal and early-onset presentations are very uncommon and their clinical course not well-described. We report on a 3-week-old hyperargininaemic girl who presented with neurological deterioration associated with liver failure and 47-day ammonia intoxication before diagnosis could be made and treatment started. Despite appropriate but delayed treatment, our patient exhibited severe psychomotor delay at age 1 year.
CONCLUSION: Early identification and management of this rare but potentially treatable affection is crucial as delayed management may result in poor neurological outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19381865     DOI: 10.1007/s10545-009-1137-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

Review 1.  A role for guanidino compounds in the brain.

Authors:  Midori Hiramatsu
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

2.  Hyperargininemia presenting as persistent neonatal jaundice and hepatic cirrhosis.

Authors:  A C Braga; L Vilarinho; E Ferreira; H Rocha
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-02       Impact factor: 2.839

3.  Argininemia treated from birth.

Authors:  S E Snyderman; C Sansaricq; P M Norton; F Goldstein
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

4.  A new case of arginase deficiency in a Spanish male.

Authors:  A Jordá; V Rubio; M Portolés; J Vilas; J García-Piño
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 5.  Hyperargininemia due to liver arginase deficiency.

Authors:  Eric A Crombez; Stephen D Cederbaum
Journal:  Mol Genet Metab       Date:  2004-12-19       Impact factor: 4.797

6.  Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia.

Authors:  Joshua L Deignan; Bart Marescau; Justin C Livesay; Ramaswamy K Iyer; Peter P De Deyn; Stephen D Cederbaum; Wayne W Grody
Journal:  Mol Genet Metab       Date:  2007-11-07       Impact factor: 4.797

7.  Arginase deficiency with lethal neonatal expression: evidence for the glutamine hypothesis of cerebral edema.

Authors:  Jonathan D Picker; Ana C Puga; Harvey L Levy; Deborah Marsden; Vivian E Shih; Umberto Degirolami; Keith L Ligon; Stephen D Cederbaum; Rita M Kern; Gerald F Cox
Journal:  J Pediatr       Date:  2003-03       Impact factor: 4.406

8.  Molecular basis of phenotypic variation in patients with argininemia.

Authors:  T Uchino; S E Snyderman; M Lambert; I A Qureshi; S K Shapira; C Sansaricq; L M Smit; C Jakobs; I Matsuda
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

Review 9.  Structure and function of arginases.

Authors:  David E Ash
Journal:  J Nutr       Date:  2004-10       Impact factor: 4.798

10.  Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders.

Authors:  Jun-ichi Takanashi; A James Barkovich; Sabrina F Cheng; Kara Weisiger; Carol O Zlatunich; Christine Mudge; Philip Rosenthal; Mendel Tuchman; Seymour Packman
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

View more
  3 in total

Review 1.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

2.  A Case of Hyperargininaemia Presenting at Unusually Low Age.

Authors:  Vanita Lal; Daisy Khera; Garima Gupta; Kuldeep Singh; Praveen Sharma
Journal:  J Clin Diagn Res       Date:  2017-07-01

3.  Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?

Authors:  Shailly Jain-Ghai; Sandesh C Sreenath Nagamani; Susan Blaser; Komudi Siriwardena; Annette Feigenbaum
Journal:  Mol Genet Metab       Date:  2011-07-13       Impact factor: 4.797

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.